In fact, CRPC tissues showed significantly higher expression of COX-2 than hormone-naïve PC tissues [20], and the inhibition of the COX-2 pathway downregulates a number of important targets of CRPC including androgen receptors [21]. This evidence concerns the gene AR and pachyonychia congenita.